p53 expression and proliferative activity in Bowen's disease with or without chronic arsenic exposure

Human Pathology

Volumn 28, Issue 7, 1997, Pages 786-790

  Kuo, Tseng Tong ^a   Hu, Sindy ^a   Lo, Sing Kai ^a   Chan, Heng Leong ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Arsenic exposure; Bowen's disease; MIB 1; p53; Proliferative activity

Indexed keywords

MONOCLONAL ANTIBODY KI 67; PROTEIN P53;

ADULT; AGED; ARTICLE; BOWEN DISEASE; CARCINOGENESIS; CELL COUNT; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LONG TERM EXPOSURE; MALE; SQUAMOUS CELL CARCINOMA;

EID: 0030806942     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(97)90150-7     Document Type: Article

References (22)

1. Yeh S, How SW, Lin CS: Arsenical cancer of skin: Histological study, with special reference to Bowen's disease. Cancer 21:312-339, 1968
2. Yeh S: Skin cancer in chronic arsenicism. HUM PATHOL 4:469-485, 1973
3. Tseng WP, Chu HM, How SW, et al: Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst 40:453-456, 1968
4. Chen CJ, Chuang YC, Lin TM, et al: Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: High-arsenic artesian well water and cancers. Cancer Res 45:5895-5899, 1985
5. Chen CJ, Kuo TL, Wu MM: Arsenic and cancers. Lancet 2:414-415, 1988
6. Nigro JM, Baker SJ, Preisinger AC, et al: Mutations in the p53 gene occur in diverse human tumour types. Nature 342:705-708, 1989
7. Bartek J, Bartkova J, Vojtesek B, et al: Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 6:1699-1703, 1991
8. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580, 1981
9. Cattoretti G, Becker MHG, Key G, et al: Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin section. J Pathol 168:357-363, 1992
10. Coulter LK, Wolber R, Tron VA: Site-specific comparison of p53 immunostaining in squamous cell carcinomas. HUM PATHOL 26:531-533, 1995
11. Rosner B: Fundamentals of Biostatics (ed 4). Belmont, CA, Duxbury Press, 1995, pp 562-568
12. Campbell C, Quiun AG, Ro YS, et al: p53 Mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin. J Invest Dermatol 100:746-748, 1993
13. Kawashima M, Jablonska S, Favre M, et al: Characterization of a new type of human papilloma virus found in a lesion of Bowen's disease of the skin. J Virol 57:688-692, 1986
14. Hsieh LL, Chen HJ, Hsieh JT, et al: Arsenic-related Bowen's disease and paraquat-related skin cancerous lesions show no detectable ras and p53 gene alterations. Cancer Lett 86:59-65, 1994
15. Shibata A, Ohneseit PF, Tsai YC, et al: Mutational spectrum in the p53 gene in bladder tumors from endemic area of black foot disease in Taiwan. Carcinogenesis 15:1085-1087, 1994
16. Gusterson BA, Anbazhagan R, Warren W, et al: Expression of p53 in premalignant and malignant squamous epithelium. Oncogene 6:1785-1789, 1991
17. Sim CS, Slater SD, McKee PH: Mutant p53 protein is expressed in Bowen's disease. Am J Dermatopathol 14:195-199, 1992
18. McGregor JM, Yu C C-W, Dublin EA, et al: Aberrant expression of p53 tumor-suppressor protein in non-melanoma skin cancer. Br J Dermatol 127:463-469, 1992
19. Ro YS, Cooper PN, Lee LA, et al: p53 Protein expression in benign and malignant skin tumors. Br J Dermatol 128:237-241, 1993
20. Hughes JH, Robinson RA: p53 Expression in Bowen's disease and in microinvasive squamous cell carcinoma of the skin. Mod Pathol 8:526-529, 1995
21. Levine AJ, Perry ME, Chang A, et al: The 1993 Walter Habert Lecture: The role of the p53 tumour-suppressor gene in tumorigenesis. Br J Cancer 69:409-416, 1994
22. Cordon-Cardo C: Mutation of cell cycle regulators: Biological and clinical implications for human neoplasia. Am J Pathol 147:545-560, 1995